Cargando…

The effect of spatial aggregation on performance when mapping a risk of disease

BACKGROUND: Spatial data on cases are available either in point form (e.g. longitude/latitude), or aggregated by an administrative region (e.g. zip code or census tract). Statistical methods for spatial data may accommodate either form of data, however the spatial aggregation can affect their perfor...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeffery, Caroline, Ozonoff, Al, Pagano, Marcello
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995615/
https://www.ncbi.nlm.nih.gov/pubmed/24625068
http://dx.doi.org/10.1186/1476-072X-13-9
_version_ 1782312899904012288
author Jeffery, Caroline
Ozonoff, Al
Pagano, Marcello
author_facet Jeffery, Caroline
Ozonoff, Al
Pagano, Marcello
author_sort Jeffery, Caroline
collection PubMed
description BACKGROUND: Spatial data on cases are available either in point form (e.g. longitude/latitude), or aggregated by an administrative region (e.g. zip code or census tract). Statistical methods for spatial data may accommodate either form of data, however the spatial aggregation can affect their performance. Previous work has studied the effect of spatial aggregation on cluster detection methods. Here we consider geographic health data at different levels of spatial resolution, to study the effect of spatial aggregation on disease mapping performance in locating subregions of increased disease risk. METHODS: We implemented a non-parametric disease distance-based mapping (DBM) method to produce a smooth map from spatially aggregated childhood leukaemia data. We then simulated spatial data under controlled conditions to study the effect of spatial aggregation on its performance. We used an evaluation method based on ROC curves to compare performance of DBM across different geographic scales. RESULTS: Application of DBM to the leukaemia data illustrates the method as a useful visualization tool. Spatial aggregation produced expected degradation of disease mapping performance. Characteristics of this degradation, however, varied depending on the interaction between the geographic extent of the higher risk area and the level of aggregation. For example, higher risk areas dispersed across several units did not suffer as greatly from aggregation. The choice of centroids also had an impact on the resulting mapping. CONCLUSIONS: DBM can be implemented for continuous and discrete spatial data, but the resulting mapping can lose accuracy in the second setting. Investigation of the simulations suggests a complex relationship between performance loss, geographic extent of spatial disturbances and centroid locations. Aggregation of spatial data destroys information and thus impedes efforts to monitor these data for spatial disturbances. The effect of spatial aggregation on cluster detection, disease mapping, and other useful methods in spatial epidemiology is complex and deserves further study.
format Online
Article
Text
id pubmed-3995615
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39956152014-05-07 The effect of spatial aggregation on performance when mapping a risk of disease Jeffery, Caroline Ozonoff, Al Pagano, Marcello Int J Health Geogr Research BACKGROUND: Spatial data on cases are available either in point form (e.g. longitude/latitude), or aggregated by an administrative region (e.g. zip code or census tract). Statistical methods for spatial data may accommodate either form of data, however the spatial aggregation can affect their performance. Previous work has studied the effect of spatial aggregation on cluster detection methods. Here we consider geographic health data at different levels of spatial resolution, to study the effect of spatial aggregation on disease mapping performance in locating subregions of increased disease risk. METHODS: We implemented a non-parametric disease distance-based mapping (DBM) method to produce a smooth map from spatially aggregated childhood leukaemia data. We then simulated spatial data under controlled conditions to study the effect of spatial aggregation on its performance. We used an evaluation method based on ROC curves to compare performance of DBM across different geographic scales. RESULTS: Application of DBM to the leukaemia data illustrates the method as a useful visualization tool. Spatial aggregation produced expected degradation of disease mapping performance. Characteristics of this degradation, however, varied depending on the interaction between the geographic extent of the higher risk area and the level of aggregation. For example, higher risk areas dispersed across several units did not suffer as greatly from aggregation. The choice of centroids also had an impact on the resulting mapping. CONCLUSIONS: DBM can be implemented for continuous and discrete spatial data, but the resulting mapping can lose accuracy in the second setting. Investigation of the simulations suggests a complex relationship between performance loss, geographic extent of spatial disturbances and centroid locations. Aggregation of spatial data destroys information and thus impedes efforts to monitor these data for spatial disturbances. The effect of spatial aggregation on cluster detection, disease mapping, and other useful methods in spatial epidemiology is complex and deserves further study. BioMed Central 2014-03-13 /pmc/articles/PMC3995615/ /pubmed/24625068 http://dx.doi.org/10.1186/1476-072X-13-9 Text en Copyright © 2014 Jeffery et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Jeffery, Caroline
Ozonoff, Al
Pagano, Marcello
The effect of spatial aggregation on performance when mapping a risk of disease
title The effect of spatial aggregation on performance when mapping a risk of disease
title_full The effect of spatial aggregation on performance when mapping a risk of disease
title_fullStr The effect of spatial aggregation on performance when mapping a risk of disease
title_full_unstemmed The effect of spatial aggregation on performance when mapping a risk of disease
title_short The effect of spatial aggregation on performance when mapping a risk of disease
title_sort effect of spatial aggregation on performance when mapping a risk of disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995615/
https://www.ncbi.nlm.nih.gov/pubmed/24625068
http://dx.doi.org/10.1186/1476-072X-13-9
work_keys_str_mv AT jefferycaroline theeffectofspatialaggregationonperformancewhenmappingariskofdisease
AT ozonoffal theeffectofspatialaggregationonperformancewhenmappingariskofdisease
AT paganomarcello theeffectofspatialaggregationonperformancewhenmappingariskofdisease
AT jefferycaroline effectofspatialaggregationonperformancewhenmappingariskofdisease
AT ozonoffal effectofspatialaggregationonperformancewhenmappingariskofdisease
AT paganomarcello effectofspatialaggregationonperformancewhenmappingariskofdisease